浅谈心血管的风险因子及其干预
摘要
随着人类疾病谱的转变，以高血压、冠状动脉粥样硬化性心脏病（冠心痛）等为代表的心血管病发病率全世界范围内日益增高。本文根据生活方式和相应影响下的风险因子对心血管病的干预措施进行了探讨。
出处
《医学信息》
2010年第5期1367-1367,共1页
Journal of Medical Information
二级参考文献17
-
1Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181.
-
2Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176.
-
3Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275.
-
4Chen ZM,Jiang LX,Chen YP,et al.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1607-1621.
-
5Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):234S-264S.
-
6Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation,2002,106:388-391.
-
7Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
-
8Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
-
9Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502.
-
10Juul-Moller S,Edvardsson N,Jahnmatz B,et al.Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.Lancet,1992,340:1421-1425.
共引文献193
-
1付宁红.心血管内分泌学:内分泌医师面临的挑战[J].医学信息（医学与计算机应用）,2014(27):585-585.
-
2陈明,王茜婷.经皮冠状动脉介入治疗抗血小板治疗现状和进展[J].中国医学前沿杂志（电子版）,2011,3(3):43-49. 被引量：8
-
3赵冬琴.21例不稳定性心绞痛阿司匹林+氯吡格雷治疗疗效观察[J].中国临床实用医学,2007,1(7). 被引量：1
-
4李小鹰.在动脉硬化性心血管病防治中规范应用阿司匹林[J].中华心血管病杂志,2006,34(5):477-480. 被引量：22
-
5韩雅玲,王效增.不稳定型心绞痛和非ST段抬高心肌梗死的介入治疗[J].中国实用内科杂志,2006,26(8):1131-1133. 被引量：10
-
6吴兆苏.多重心血管病危险综合防治建议[J].中华心血管病杂志,2006,34(12):1061-1071. 被引量：120
-
7李宇华,李学军.剂量与药物治疗及药物发现的关系[J].医药导报,2007,26(1):1-5. 被引量：2
-
8孙卫东.阿司匹林在心血管病防治中的合理应用[J].中国社区医师,2007,23(2):15-16. 被引量：1
-
9崔忠太,邵秀芹,孙庆华,黄浩.某学院校医院门诊处方中不合理用药问题分析[J].中国校医,2007,21(1):42-43. 被引量：1
-
10阮淑萍.阿司匹林抵抗[J].浙江实用医学,2007,12(1):74-75.
-
1王爱军.心血管病的一级预防策略分析[J].医学信息,2010,23(4):1127-1128.
-
2戚文航.心房颤动一级预防策略的知与行我们能做什么？[J].中华心血管病杂志,2013,41(11):909-910.
-
3刘文忠.根除幽门螺杆菌预防胃癌:希望和困惑[J].胃肠病学,2015,20(1):2-4. 被引量：14
-
4何英武,李联.中性粒细胞CD64生物学特性及其在疾病中的研究进展[J].山西医药杂志,2014,43(14):1670-1672. 被引量：1
-
5Waltraud Eder.最新观念哮喘流行[J].中国农村医学杂志,2007,5(1):75-78.
-
6詹森,邓超.基因筛查能改变患者行为从而减少2型糖尿病风险吗?[J].糖尿病天地（临床）,2013(2):86-87.
-
7宗音,许丹焰.话说血脂异常[J].生活与健康,2010(6):6-9.
-
8林峰.功能性胃肠病的研究新进展[J].中国医药指南,2013,11(9):76-78. 被引量：12
-
9杨敏,杨彩燕,杨爽.A型行为冠心病病人行为改变动力来源的质性研究[J].护理研究（中旬版）,2009,23(6):1546-1547. 被引量：3
-
10章倩莹,陈楠.肾病请关注贫血治疗[J].家庭用药,2011(3):40-40.
